Clinical Trial Update: RFA vs. SBRT for Small HCC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing radiofrequency ablation (RFA) versus stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma is in early status with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN